Wortmannin (SL-2052) is a potent, irreversible, and noncompetitive PI3K inhibitor. It affects the PI3K/Akt/mTOR signaling pathway by binding to the p110 catalytic subunit, effectively inhibiting autophagy, cell proliferation, and migration, while promoting apoptosis.
Wortmannin (SL-2052) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Wortmannin (SL-2052) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- Wortmannin (SL-2052) Mechanism of Action: PI3K Inhibition in Cancer Cell Research
- Wortmannin (SL-2052): Selectivity & Specificity
- Wortmannin (SL-2052) Working Concentration | Cell Culture | Treatment
- Wortmannin (SL-2052) Solubility in DMSO
- Wortmannin (SL-2052) Stock Solution
- Wortmannin (SL-2052) Storage
- Wortmannin (SL-2052) Stability
- Wortmannin (SL-2052) Combination Database
- Wortmannin (SL-2052) Molecular Weight
- Wortmannin (SL-2052) SMILES
- Wortmannin (SL-2052) CAS Number
- Wortmannin (SL-2052) Chemical Structure (2D and 3D)
- Wortmannin (SL-2052) Sigma (681675)? Try a better option.
- Wortmannin (SL-2052) MedChemExpress (HY-10197)? Try a better option.
- Wortmannin (SL-2052) Cayman (10010591)? Try a better option.
- Wortmannin (SL-2052) Tocris (1232)? Try a better option.
- Wortmannin (SL-2052) CST (9951)? Try a better option.
- Wortmannin (SL-2052) SDS｜MSDS